RESMED INC — Director's Dealing 2011

Jan 11, 2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name	of entity	ResMed Inc. (RMD)
ABN	46 064	514 852

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Kieran Gallahue
Date of last notice	December 24, 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change	Jan. 6, 2011 (equivalent to US datedtransaction of Jan. 5, 2011on theNYSE)
No. of securities held prior to change	56,921.794 shares1,440,000 options
Class	COMMON STOCK
Number acquired
Number disposed	32,590 stock options
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	US$457,400.65

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	56,921.794 shares1,407,410 options
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	On-market trade pursuant to 10b5-1 plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation
Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed periodwhere prior written clearance was required?	Yes.
If so, was prior written clearance provided to allowthe trade to proceed during this period?	Yes.
If prior written clearance was provided, on whatdate was this provided?	10b5-1 trading plan executedand approved May 11, 2010 byGeneral Counsel

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011